The pill questionnaire in a nondemented Parkinson's disease population
dc.contributor.author | Reginold, William | en_US |
dc.contributor.author | Armstrong, Melissa J. | en_US |
dc.contributor.author | Duff‐canning, Sarah | en_US |
dc.contributor.author | Lang, Anthony | en_US |
dc.contributor.author | Tang‐wai, David | en_US |
dc.contributor.author | Fox, Susan | en_US |
dc.contributor.author | Rothberg, Brandon | en_US |
dc.contributor.author | Zadikoff, Cindy | en_US |
dc.contributor.author | Kennedy, Nancy | en_US |
dc.contributor.author | Gill, David | en_US |
dc.contributor.author | Eslinger, Paul | en_US |
dc.contributor.author | Mapstone, Mark | en_US |
dc.contributor.author | Chou, Kelvin | en_US |
dc.contributor.author | Persad, Carol | en_US |
dc.contributor.author | Litvan, Irene | en_US |
dc.contributor.author | Mast, Benjamin | en_US |
dc.contributor.author | Marras, Connie | en_US |
dc.date.accessioned | 2012-10-02T17:20:20Z | |
dc.date.available | 2013-10-18T17:47:30Z | en_US |
dc.date.issued | 2012-09-01 | en_US |
dc.identifier.citation | Reginold, William; Armstrong, Melissa J.; Duff‐canning, Sarah ; Lang, Anthony; Tang‐wai, David ; Fox, Susan; Rothberg, Brandon; Zadikoff, Cindy; Kennedy, Nancy; Gill, David; Eslinger, Paul; Mapstone, Mark; Chou, Kelvin; Persad, Carol; Litvan, Irene; Mast, Benjamin; Marras, Connie (2012). "The pill questionnaire in a nondemented Parkinson's disease population ." Movement Disorders 27(10): 1308-1311. <http://hdl.handle.net/2027.42/93736> | en_US |
dc.identifier.issn | 0885-3185 | en_US |
dc.identifier.issn | 1531-8257 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/93736 | |
dc.description.abstract | We assessed the Pill Questionnaire as a screen for mild cognitive impairment in nondemented Parkinson's disease patients. The relationship between ability to remember medications for Parkinson's disease in the Pill Questionnaire, mild cognitive impairment, and deficits on neuropsychological tests performed 2–3 weeks later blind to Pill Questionnaire results was assessed in movement disorders clinic patients. In 109 subjects, inaccurate medication reporting on the Pill Questionnaire was associated with lower scores on the Montreal Cognitive Assessment, Scales for Outcomes in Parkinson's Disease–Cognition and with deficits in memory, attention, executive function‐inhibitory control, processing speed, visuospatial function, and language. Inaccurate medication reporting was also associated with an adjusted odds ratio of 2.4 (95% CI, 0.91–5.88; P = .06) for mild cognitive impairment, with a specificity of 80% and sensitivity of 41%. The Pill Questionnaire is neither sensitive nor specific enough to be used as the sole screening or diagnostic tool for mild cognitive impairment. However, inaccurate medication reporting is associated with deficits spanning many cognitive domains and should alert a clinician to a higher likelihood of cognitive impairment. © 2012 Movement Disorder Society | en_US |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | Pill Questionnaire | en_US |
dc.subject.other | Cognitive Impairment | en_US |
dc.subject.other | Screening | en_US |
dc.subject.other | MCI | en_US |
dc.subject.other | Parkinson's Disease | en_US |
dc.title | The pill questionnaire in a nondemented Parkinson's disease population | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationum | Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationother | Toronto Western Hospital Movement Disorders Centre, and the Edmond J. Safra Program in Parkinson's Disease, Toronto, Ontario, Canada | en_US |
dc.contributor.affiliationother | Department of Medicine (Neurology), University of Toronto, Toronto, Ontario, Canada | en_US |
dc.contributor.affiliationother | Department of Neuropsychology, Toronto Western Hospital, Toronto, Ontario, Canada | en_US |
dc.contributor.affiliationother | Department of Neurology, Northwestern University, Chicago, Illinois, USA | en_US |
dc.contributor.affiliationother | Department of Psychiatry and Behavioral Science, Northwestern University, Chicago, Illinois, USA | en_US |
dc.contributor.affiliationother | Department of Neurology, PennState Hershey, Hershey, Pennsylvania, USA | en_US |
dc.contributor.affiliationother | Department of Neurology, University of Rochester, Rochester, New York, USA | en_US |
dc.contributor.affiliationother | Department of Neurology, University of Louisville, Louisville, Kentucky, USA | en_US |
dc.contributor.affiliationother | Psychological & Brain Sciences, University of Louisville, Louisville, Kentucky, USA | en_US |
dc.contributor.affiliationother | Movement Disorders Centre, McL 7‐421, Toronto Western Hospital, 399 Bathurst Street, Toronto, Ontario M5T 2S8, Canada | en_US |
dc.identifier.pmid | 22865587 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/93736/1/25124_ftp.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/93736/2/MDS_25124_sm_SuppTables.pdf | |
dc.identifier.doi | 10.1002/mds.25124 | en_US |
dc.identifier.source | Movement Disorders | en_US |
dc.identifier.citedreference | Hoops S, Nazem S, Siderowf AD, et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology. 2009; 73: 1738 – 1745. | en_US |
dc.identifier.citedreference | Janvin CC, Larsen JP, Aarsland D, Hugdahl K. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord. 2006; 21: 1343 – 1349. | en_US |
dc.identifier.citedreference | Litvan I, Aarsland D, Adler CH, et al. MDS task force on mild cognitive impairment in Parkinson's disease: critical review of PD‐MCI. Mov Disord. 2011; 26: 1814 – 1824. | en_US |
dc.identifier.citedreference | Litvan I, Goldman JG, Troster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord. 2012; 27; 349 – 356. | en_US |
dc.identifier.citedreference | Caviness JN, Driver‐Dunckley E, Connor DJ, et al. Defining mild cognitive impairment in Parkinson's disease. Mov Disord. 2007; 22: 1272 – 1277. | en_US |
dc.identifier.citedreference | Benton AL, Sivan AB, Hamsher K, Varney NR, Spreen O. Contributions to Neuropsychological Assessment: A Clinical Manual. 2nd ed. New York: Oxford; 1994. | en_US |
dc.identifier.citedreference | Delis DC, Kaplan E, Kramer JH. Delis–Kaplan Executive Function System (D‐KEFS): Examiner's Manual. San Antonio, TX: The Psychological Corporation; 2001. | en_US |
dc.identifier.citedreference | Liepelt‐Scarfone I, Graeber S, Feseker A, et al. Influence of different cut‐off values on the diagnosis of mild cognitive impairment in Parkinson's disease. Parkinsons Dis. 2011; 2011: 540843. | en_US |
dc.identifier.citedreference | Wicklund AH, Johnson N, Weintraub S. Preservation of reasoning in primary progressive aphasia: further differencitation from Alzheimer's disease and the behavioral presentation of frontotemporal dementia. J Clin Exp Neuropsychol. 2004; 26: 347 – 355. | en_US |
dc.identifier.citedreference | Wechsler D. Wechsler Memory Scale. 3rd ed. San Antonio, TX: The Psychological Corporation; 1997. | en_US |
dc.identifier.citedreference | Delis D, Kramer JH, Kaplan E, Ober B. The California Verbal Learning Test. 2nd ed. San Antonio, TX: The Psychological Corporation; 2000. | en_US |
dc.identifier.citedreference | Dujardin K, Dubois B, Tison F, et al. Parkinson's disease dementia can be easily detected in routine clinical practice. Mov Disord. 2010; 25: 2769 – 2776. | en_US |
dc.identifier.citedreference | Dubois B, Burn D, Goetz C, et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord. 2007; 22: 2314 – 2324. | en_US |
dc.identifier.citedreference | Dalrymple‐Alford JC, Livingston L, MacAskill MR, et al. Characterizing mild cognitive impairment in Parkinson's disease. Mov Disord. 2011; 26: 629 – 636. | en_US |
dc.identifier.citedreference | Dalrymple‐Alford JC, MacAskill MR, Nakas CT, et al. The MoCA: well‐suited screen for cognitive impairment in Parkinson disease. Neurology. 2010; 75: 1717 – 1725. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.